Search research articles
Contact Us
Filters
Showing results (171-180 of 209) with videos related to
Page
of 21
Sort By:
Blood
|
February 12, 2017
Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents
Malte Asshoff, Verena Petzer, Matthew R Warr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
Andreas du Bois, Beatrice Weber, Justine Rochon, et al.
Oncotarget
|
May 14, 2015
Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment
Tim Schumann, Till Adhikary, Annika Wortmann, et al.
Nature Communications
|
April 10, 2015
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K Witkiewicz, Elizabeth A McMillan, Uthra Balaji, et al.
American Journal of Translational Research
|
March 23, 2019
Loss of Jak2 protects cardiac allografts from chronic rejection by attenuating Th1 response along with increased regulatory T cells
Hassan Mohammed Khair Ibrahim Higazi, Long He, Jing Fang, et al.
Breast Cancer Research : BCR
|
July 7, 2025
Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma
Rayane Dennaoui, Patrick D Rädler, Madison N Wicker, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 17, 2020
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial
Annette Hasenburg, Jalid Sehouli, Bjoern Lampe, et al.
Iscience
|
December 4, 2023
TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion
Anna Mary Steitz, Clarissa Schröder, Isabel Knuth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
Eric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist, et al.
Molecular Oncology
|
October 25, 2018
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment
Silke Reinartz, Sonja Lieber, Jelena Pesek, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 209) with videos related to
Sort By:
Page
of 21
Blood
|
February 12, 2017
Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents
Malte Asshoff, Verena Petzer, Matthew R Warr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
Andreas du Bois, Beatrice Weber, Justine Rochon, et al.
Oncotarget
|
May 14, 2015
Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment
Tim Schumann, Till Adhikary, Annika Wortmann, et al.
Nature Communications
|
April 10, 2015
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K Witkiewicz, Elizabeth A McMillan, Uthra Balaji, et al.
American Journal of Translational Research
|
March 23, 2019
Loss of Jak2 protects cardiac allografts from chronic rejection by attenuating Th1 response along with increased regulatory T cells
Hassan Mohammed Khair Ibrahim Higazi, Long He, Jing Fang, et al.
Breast Cancer Research : BCR
|
July 7, 2025
Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma
Rayane Dennaoui, Patrick D Rädler, Madison N Wicker, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 17, 2020
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial
Annette Hasenburg, Jalid Sehouli, Bjoern Lampe, et al.
Iscience
|
December 4, 2023
TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion
Anna Mary Steitz, Clarissa Schröder, Isabel Knuth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
Eric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist, et al.
Molecular Oncology
|
October 25, 2018
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment
Silke Reinartz, Sonja Lieber, Jelena Pesek, et al.
Page
of 21